Location: THE COSMOS CLUB, 2121 Massachusetts Ave, NW, Washington, DC 20006

Please join us for the Winter Meeting on 1st of May 2024

Cocktails start at 6:00 PM and dinner is served at 6:45 PM

Dr. Roselyn E. Epps, M.D. will convene the Annual Meeting at 7:15 PM

The speaker will be introduced at 7:30 PM

Please RSVP by 17 April 2024 with the Secretary at Secretary@acadmeddc.org. Fee for a guest is $60, payable by check at the meeting. Please let the Secretary know of any special dietary requests.

---

---

About the Speaker

Dr. Ivonne Hernandez Schulman received her medical degree from the University of Miami (UM) Miller School of Medicine. She completed her Internal Medicine residency and Nephrology clinical and research fellowships at UM/Jackson Memorial Hospital and Veterans Affairs Medical Center and joined the UM School of Medicine and VA Medical Center as Assistant Professor in 2004. In addition to working as a clinical nephrologist and hypertension specialist and supervising residents and fellows, she is a physician-scientist with expertise in cardiovascular and renal molecular biology, stem cell culture techniques, and the design and implementation of stem cell preclinical studies and phase I/II clinical protocols and investigational new drug applications for the treatment of cardiovascular diseases, chronic kidney disease, and frailty. She was Professor of Clinical Medicine at the UM Miller School of Medicine until September 2019, at which time she joined the Division of Kidney, Urologic and Hematologic Diseases at the National Institute of Diabetes, Digestive and Kidney Diseases as Senior Scientific Advisor for Acute Renal Failure and Renal Pathophysiology and Program Director, Translational and Clinical Studies of Acute Kidney Injury (AKI). Her responsibilities include overseeing and managing research portfolios associated with developing novel diagnostic and therapeutic strategies as well as research on the natural history of AKI, including studies on risk and outcome stratification, for early stages and progression to chronic kidney disease. She also contributes to the scientific and programmatic management of single site and multi-institutional studies of AKI, as well as epidemiology and health equity in kidney diseases.